港股异动 | 先瑞达医疗-B(06669)午后涨近5% 公司继续与波士顿科学深化战略合作

Group 1 - The core viewpoint of the article highlights that Xianruida Medical-B (06669) has seen a nearly 5% increase in stock price following the announcement of a strategic partnership with Boston Scientific [1] - The collaboration includes a total cooperation agreement and a total service agreement, aimed at deepening the strategic partnership established in 2023 [1] - Over the next three years, Boston Scientific is set to purchase Xianruida's products for global sales, with a transaction cap of $170 million [1]